Original research / Ambiq Micro

Ambiq Micro’s Cash Rose to US$363 Million, but What Does It Mean for Dividends?

Ambiq Micro’s sales nearly doubled in the first nine months of 2026, yet operating cash outflow increased. Its much larger cash balance followed share offerings, so it should not be mistaken for cash generated by the business or a sign of an imminent dividend.

Dividends.sg ·

Ambiq Micro (SGX: AMQ) ended September 2026 with US$363.5 million in cash and cash equivalents, up from US$140.3 million at the end of 2025. For a dividend investor, the question is where that extra cash came from. Ambiq completed its secondary SGX listing in July; these unaudited nine-month results were filed in November. [S1, p. 3] [S1, p. 7]

The answer is principally share financing. Ambiq’s business grew quickly, but it still used cash in its operations. That makes the cash balance a measure of its capacity to fund growth, rather than evidence of cash available from recurring operations for a payout. [S1, p. 6] [S1, p. 21]

Sales growth has yet to turn into operating cash

Net sales reached US$97.1 million for the nine months ended 30 September 2026, compared with US$51.8 million a year earlier—an increase of about 88%. The third quarter alone contributed US$38.1 million, more than double the year-earlier quarter. Ambiq attributed the growth mainly to new product launches and increased use of newer products by major customers. [S1, p. 4] [S1, p. 19]

The nine-month net loss narrowed slightly, from US$25.8 million to US$24.3 million. Yet net cash used in operating activities rose from US$15.6 million to US$25.4 million. The difference matters: profit and cash flow measure different things, and higher sales did not translate into stronger operating cash generation during this period. [S1, p. 4] [S1, p. 6]

Working capital helps explain the cash strain. The cash-flow statement shows a US$13.1 million inventory increase and an US$11.7 million increase in receivables. Management described US$17.3 million of unfavourable working-capital changes overall. Those movements may reflect a growing business, but they also tie up cash until inventory is sold and customers pay. [S1, p. 6] [S1, p. 22]

The larger cash balance came from financing

Ambiq used another US$7.7 million in investing activities during the nine months, including purchases of intangible assets and equipment. Combining operating and investing cash flows gives an outflow of US$33.1 million. Financing activities, by contrast, provided US$256.2 million; the cash-flow statement records US$245.5 million of proceeds from follow-on share offerings before the separately presented deferred offering-cost payment. [S1, p. 6]

The balance sheet therefore offers substantial financial breathing room, but its increase should not be read as a dividend signal. Management said in its November filing that it expected cash on hand and anticipated operating cash to fund operations for at least the following twelve months. It also said it expected continued losses while investing in product development. That is a statement about funding the business, not a commitment to distribute cash. [S1, p. 21]

What would change the dividend picture?

Ambiq’s filing says common-share dividends are at the board’s discretion. It reports an accumulated deficit of US$381.1 million at 30 September 2026. Neither the large cash balance nor the stronger sales figure establishes a dividend entitlement. [S1, p. 3] [S1, p. 11]

For investors seeking income, the useful next evidence is whether sales growth begins to produce sustained operating cash inflows after inventory and receivables are funded. Until then, Ambiq’s September results describe a company financing expansion with capital raised from shareholders, rather than one demonstrating cash generation for regular dividends. [S1, p. 6] [S1, p. 21]